To be honest, when I first looked at the charts/tables in today's ann my initial reaction was disappointment that the differential between the Predicted HCQ+CBD and Actual HCQ+CBD was significantly less than the differential we saw in the in vitro results but then saw that this was after only 2 hours compared to 24 hours for in vitro.
The guys probably chose a shorter time frame here to accentuate how quickly this could take effect if we're going to potentially administer it to gravely ill COVID sufferers perhaps??
- Forums
- ASX - By Stock
- IHL
- Ann: Positive IHL-675A in vivo results and FDA Pathway
Ann: Positive IHL-675A in vivo results and FDA Pathway, page-81
-
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)